Pulmonx
Nick Woodcock has a diverse work experience in sales and management roles in the medical field. Nick has worked for Pulmonx Corporation since 2012, holding positions such as Area Vice President of Sales for EMEA and Director of Sales for the UK and Northern Europe. Before that, they were employed at Atrium Medical as a UK Sales Manager and Territory Manager. Prior to Atrium Medical, they worked at Vygon as a Sales Executive. Nick started their career at McKenna Group as a Sales Engineer.
Nick Woodcock attended Birmingham City University, where they pursued studies in Business & Finance. No specific start or end year for their education is provided.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1